The neoepitope VGPEILSSL (which elicited the strongest CD8+ T cell response but no tumor rejection on immunization of naive mice in Figure 2, A and E) showed significant CD8+ T cell response in tumor-bearing mice (Figure 2F). This evidence concerns the gene CD8A and neoplasm.